From January 1, 2023 to March 31, 2023, the company has repurchased 0 shares, representing 0% for KRW 0 million. With this, the company has completed the repurchase of 294,186 shares, representing 0.87% for KRW 2,998.6 million under the buyback announced on September 20, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
6,520 KRW | -0.31% | -5.78% | -25.74% |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-25.74% | 159M | |
+7.51% | 111B | |
+11.38% | 106B | |
-12.61% | 22.24B | |
+0.44% | 21.25B | |
-4.18% | 18.97B | |
-37.85% | 18.52B | |
-8.49% | 16.81B | |
+37.48% | 12.54B | |
-23.85% | 8.09B |
- Stock Market
- Equities
- A048530 Stock
- News iNtRON Biotechnology, Inc.
- Tranche Update on iNtRON Biotechnology, Inc.'s Equity Buyback Plan announced on September 20, 2022.